| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| PSA-M82E3 | Mouse | Biotinylated Mouse PSCA Protein, His,Avitag™ (MALS verified) |  |
|
|
| PSA-H82E3 | Human | Biotinylated Human PSCA Protein, His,Avitag™ (MALS verified) |  |
|
|
| PSA-H52H6 | Human | Human PSCA Protein, His Tag |  |
|
2e5 of anti-PSCA CAR-293 cells were stained with 100 μL of 3 μg/mL of Biotinylated Human PSCA, His,Avitag (Cat. No. PSA-H82E3) and negative control protein respectively, washed and then followed by PE-SA antibody and analyzed with FACS (Routinely tested).
Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.
The purity of Biotinylated Human PSCA, His,Avitag (Cat. No. PSA-H82E3) is more than 90% and the molecular weight of this protein is around 18-25 kDa verified by SEC-MALS.
2e5 of anti-PSCA CAR-293 cells were stained with 100 μL of 3 μg/mL of Biotinylated Human PSCA, His,Avitag (Cat. No. PSA-H82E3) and negative control protein respectively, washed and then followed by PE-SA antibody and analyzed with FACS (Routinely tested).
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| BPX-601 | BPX-601 | Phase 2 Clinical | Bellicum | Pancreatic Neoplasms; Urinary Bladder Neoplasms; Prostatic Neoplasms; Esophageal adenocarcinoma; Carcinoma, Pancreatic Ductal | Details |
| 124-iodine-labeled PSCA targeting minibody (ImaginAb) | Phase 1 Clinical | University Of California At Los Angeles | Pancreatic Neoplasms; Urinary Bladder Neoplasms; Prostatic Neoplasms | Details | |
| GEM3-PSCA | GEM3-PSCA | Phase 1 Clinical | Gemoab Monoconals, Gcp Service International | Kidney Neoplasms; Carcinoma, Transitional Cell; Pancreatic Neoplasms; Prostatic Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
This web search service is supported by Google Inc.
A-Z
